Compile Data Set for Download or QSAR
Report error Found 331 Enz. Inhib. hit(s) with all data for entry = 8120
TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234186(US9353090, 319)
Affinity DataEC50:  1nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234168(US9353090, 301)
Affinity DataEC50:  1nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233881(US9353090, 9)
Affinity DataEC50:  1nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234162(US9353090, 293)
Affinity DataEC50:  1nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233970(US9353090, 98)
Affinity DataEC50:  1nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234193(US9353090, 326)
Affinity DataEC50:  1nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233964(US9353090, 93 | US9353090, 92)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234122(US9353090, 252)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233958(US9353090, 86)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233959(US9353090, 87)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233906(US9353090, 34)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234195(US9353090, 330 | US9353090, 328)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234160(US9353090, 291)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233968(US9353090, 96)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233969(US9353090, 97)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234190(US9353090, 323)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234191(US9353090, 324)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233967(US9353090, 95)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234141(US9353090, 272)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234170(US9353090, 303)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234139(US9353090, 270)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233977(US9353090, 105)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233989(US9353090, 117)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233890(US9353090, 18)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233984(US9353090, 112)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234111(US9353090, 241)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233887(US9353090, 15)
Affinity DataEC50:  2nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234188(US9353090, 321)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233963(US9353090, 91)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233991(US9353090, 119)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233972(US9353090, 100)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234068(US9353090, 196)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233877(US9353090, 5)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233973(US9353090, 101)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234130(US9353090, 261)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234131(US9353090, 262)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233875(US9353090, 3)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233971(US9353090, 99)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234161(US9353090, 292)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234126(US9353090, 256)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233966(US9353090, 94)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234127(US9353090, 257)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233999(US9353090, 127)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234173(US9353090, 306)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234169(US9353090, 302)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233878(US9353090, 6)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM233974(US9353090, 102)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234178(US9353090, 311)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234179(US9353090, 312)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

TargetGuanylate cyclase soluble subunit alpha-1/beta-1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM234113(US9353090, 243)
Affinity DataEC50:  3nMT: 2°CAssay Description:The sGC cellular activator assay is performed in the presence and absence of 50% human serum (HS) using Chinese hamster ovary cells that have been st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2017
Entry Details
US Patent

Displayed 1 to 50 (of 331 total ) | Next | Last >>
Jump to: